Skip to main content
. Author manuscript; available in PMC: 2020 Mar 31.
Published in final edited form as: J Allergy Clin Immunol Pract. 2019 Mar 13;7(7):2422–2424.e4. doi: 10.1016/j.jaip.2019.02.039

Table 2.

Prenatal exposure to acid suppressant medications and risk of recurrent wheeze by age 3 years

Exposed
(n=144, cases=56)
Unexposed
(n=756, cases=233)
Cox-proportional hazards*
 Unadjusted 1.38 (1.03–1.85) 1.00 (reference)
 Adjusted Model A 1.40 (1.03–1.89) 1.00 (reference)
 Adjusted Model B 1.40 (1.02–1.91) 1.00 (reference)
*

All models were stratified by age at enrollment.

Model A: Adjusted for sex, insurance, race/ethnicity and median household income.

Model B: Adjusted for sex, insurance, race/ethnicity, median household income, maternal history of atopic disease (asthma, allergic rhinitis, food allergy and eczema), maternal smoking during pregnancy, gestational age at birth, multiple gestation (e.g. twin), mode of delivery and maternal use of antibiotics during pregnancy prior to labor.

Statistically significant with P <0.05.